Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMC 1773452)

Published in Gut on December 01, 2002

Authors

F M Ruemmele1, J F Beaulieu, S Dionne, E Levy, E G Seidman, N Cerf-Bensussan, M J Lentze

Author Affiliations

1: Laboratory of Gastrointestinal Immunology, Division of Gastroenterology, Department of Paediatrics, Children's Hospital Medical Centre, University of Bonn, Bonn, Germany. ruemmele@necker.fr

Articles citing this

Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology (2006) 2.78

Microbial translocation across the GI tract. Annu Rev Immunol (2012) 2.30

Toll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis. J Clin Invest (2016) 1.52

Mechanisms of decreased intestinal epithelial proliferation and increased apoptosis in murine acute lung injury. Crit Care Med (2005) 1.49

No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med (2008) 1.46

A Host-Produced Autoinducer-2 Mimic Activates Bacterial Quorum Sensing. Cell Host Microbe (2016) 1.39

HIV-associated chronic immune activation. Immunol Rev (2013) 1.38

The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol (2009) 1.35

Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ? World J Gastroenterol (2006) 1.35

Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis. J Biol Chem (2012) 1.31

Kruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells. Nucleic Acids Res (2006) 1.28

Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J Gastroenterol (2005) 1.19

Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factor. Immunology (2006) 1.00

Tumor necrosis factor-{alpha} downregulates intestinal NHE8 expression by reducing basal promoter activity. Am J Physiol Cell Physiol (2008) 1.00

TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions. PLoS One (2011) 0.98

Mucosal immunity in human and simian immunodeficiency lentivirus infections. Mucosal Immunol (2013) 0.96

Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9. Am J Physiol Gastrointest Liver Physiol (2014) 0.94

SCF(Fbxw15) mediates histone acetyltransferase binding to origin recognition complex (HBO1) ubiquitin-proteasomal degradation to regulate cell proliferation. J Biol Chem (2013) 0.91

Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor. Mucosal Immunol (2015) 0.87

DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma. Am J Physiol Gastrointest Liver Physiol (2011) 0.86

Bacterial translocation to mesenteric lymph nodes increases in chronic portal hypertensive rats. Dig Dis Sci (2009) 0.85

LPS receptor subunits have antagonistic roles in epithelial apoptosis and colonic carcinogenesis. Cell Death Differ (2015) 0.84

Intestinal glucose uptake protects liver from lipopolysaccharide and D-galactosamine, acetaminophen, and alpha-amanitin in mice. Am J Pathol (2009) 0.82

Intestinal apoptotic changes linked to metabolic status in fasted and refed rats. Pflugers Arch (2005) 0.79

Inherent potential for production of tumor necrosis factor-alpha by human intestinal macrophages. Int J Colorectal Dis (2005) 0.79

Pathophysiological mechanisms of death resistance in colorectal carcinoma. World J Gastroenterol (2015) 0.78

Mitogen-activated protein kinase phosphatase-1 prevents lipopolysaccharide-induced apoptosis in immature rat intestinal epithelial cells. Pediatr Res (2015) 0.77

Cardiolipins Act as a Selective Barrier to Toll-Like Receptor 4 Activation in the Intestine. Appl Environ Microbiol (2016) 0.75

Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections. Front Immunol (2017) 0.75

Articles cited by this

Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (1990) 17.86

Toll-like receptors in the induction of the innate immune response. Nature (2000) 12.23

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67

Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology (1998) 9.58

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med (1999) 9.23

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet (1992) 6.66

Pathogenetic mechanisms of septic shock. N Engl J Med (1993) 6.64

Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature (1998) 6.49

Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet (1991) 5.02

Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology (1994) 5.00

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39

Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A (1993) 4.35

Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol (2000) 4.32

Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol (2000) 4.12

Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol (2000) 4.10

Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol (2001) 3.59

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol (1990) 3.54

Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem (2000) 3.06

T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol (1997) 2.76

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci (1992) 2.47

Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest (1998) 2.32

Significance of systemic endotoxaemia in inflammatory bowel disease. Gut (1995) 2.21

Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol (2000) 2.16

IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol (1999) 1.83

Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr Opin Microbiol (1999) 1.75

Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology (1997) 1.67

Use of the dissociating enzyme thermolysin to generate viable human normal intestinal epithelial cell cultures. Exp Cell Res (1996) 1.65

Cytokine production by epithelial cells. FASEB J (1994) 1.60

The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J Immunol (1998) 1.29

Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. J Immunol (1997) 1.29

Tyrosine kinase and MAPK inhibition of TNF-alpha- and EGF-stimulated IEC-6 cell growth. Biochem Biophys Res Commun (1998) 0.95

A synergistic relationship between TNF-alpha, IL-1 beta, and TGF-beta 1 on IL-6 secretion by the IEC-6 intestinal epithelial cell line. Immunology (1995) 0.95

Susceptibility to FAS-induced apoptosis in human nontumoral enterocytes: role of costimulatory factors. J Cell Physiol (1999) 0.94

TNFalpha-induced IEC-6 cell apoptosis requires activation of ICE caspases whereas complete inhibition of the caspase cascade leads to necrotic cell death. Biochem Biophys Res Commun (1999) 0.92

Bacterial lipopolysaccharide reduced intestinal barrier function and altered localization of 7H6 antigen in IEC-6 rat intestinal crypt cells. J Cell Physiol (1997) 0.88

Articles by these authors

Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J Cell Sci (1999) 4.36

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol (1998) 3.79

Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. J Exp Med (1991) 3.63

Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet (2000) 3.47

Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology (2001) 3.33

AP-2/Eps15 interaction is required for receptor-mediated endocytosis. J Cell Biol (1998) 3.30

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology (2000) 2.99

Intraepithelial lymphocytes modulate Ia expression by intestinal epithelial cells. J Immunol (1984) 2.84

Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2. J Exp Med (1983) 2.61

The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol (1996) 2.57

Localization of the X inactivation centre on the human X chromosome in Xq13. Nature (1991) 2.48

Immunohistologic and immunoelectron microscopic characterization of the mucosal lymphocytes of human small intestine by the use of monoclonal antibodies. J Immunol (1983) 2.44

Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther (2014) 2.42

Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology (1998) 2.38

Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord (2004) 2.26

Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease. Aliment Pharmacol Ther (2013) 2.12

The tyrosine kinase substrate eps15 is constitutively associated with the plasma membrane adaptor AP-2. J Cell Biol (1995) 2.06

Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med (2001) 2.05

Adult celiac disease with severe or partial villous atrophy: a comparative study. Gastroenterol Clin Biol (2008) 2.04

Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst (1996) 1.93

The ear of alpha-adaptin interacts with the COOH-terminal domain of the Eps 15 protein. J Biol Chem (1996) 1.93

Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis (1987) 1.92

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy. Inflamm Bowel Dis (2001) 1.77

Intraepithelial lymphocytes of human gut: isolation, characterisation and study of natural killer activity. Gut (1985) 1.76

Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology (1998) 1.71

Successful small bowel transplantation in an infant. Transplantation (1992) 1.69

Subsets of CD3+ (T cell receptor alpha/beta or gamma/delta) and CD3- lymphocytes isolated from normal human gut epithelium display phenotypical features different from their counterparts in peripheral blood. Eur J Immunol (1990) 1.67

Use of the dissociating enzyme thermolysin to generate viable human normal intestinal epithelial cell cultures. Exp Cell Res (1996) 1.65

Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64

Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut (2004) 1.62

Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child (1991) 1.61

Effectiveness of antigliadin antibodies as a screening test for celiac disease in children. CMAJ (1997) 1.59

Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res (2001) 1.57

Literature review and recommendations for clinical application of small-bowel capsule endoscopy, based on a panel discussion by international experts. Consensus statements for small-bowel capsule endoscopy, 2006/2007. Endoscopy (2007) 1.55

Primary cultures of fully differentiated and pure human intestinal epithelial cells. Exp Cell Res (1998) 1.54

Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol (2008) 1.53

Distinct patterns of cow's milk allergy in infancy defined by prolonged, two-stage double-blind, placebo-controlled food challenges. Clin Exp Allergy (1996) 1.51

Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. Arch Dermatol (2001) 1.50

Cisapride reduces postoperative gastrocaecal transit time after cardiac surgery in children. Intensive Care Med (1996) 1.50

Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurology (2011) 1.48

Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II. N Engl J Med (1991) 1.48

Monoclonal antibody (HML-1) reactivity of T-cell lymphomas. Lancet (1989) 1.45

The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes Res (2001) 1.45

A clinical rating scale for Batten disease: reliable and relevant for clinical trials. Neurology (2005) 1.45

Iatrogenic pneumocephalus secondary to intravenous catheterization. Case report. J Neurosurg (1999) 1.44

Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice. Gut (2003) 1.44

Mapping of Eps15 domains involved in its targeting to clathrin-coated pits. J Biol Chem (2000) 1.44

Increased HLA-DR expression by enterocytes in children with celiac disease. Gastroenterology (1986) 1.40

Biosynthesis and maturation of lactase-phlorizin hydrolase in the human small intestinal epithelial cells. Biochem J (1987) 1.39

Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome. Am J Kidney Dis (2000) 1.39

Assessing the value of employee training. Health Care Manage Rev (1988) 1.39

Chlamydia infection of epithelial cells expressing dynamin and Eps15 mutants: clathrin-independent entry into cells and dynamin-dependent productive growth. J Cell Sci (1999) 1.38

Non-pancreatic hydrolysis of N-benzoyl-l-tyrosyl-p-aminobenzoic acid (PABA-peptide) in the human small intestine. Clin Sci (Lond) (1982) 1.37

Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). J Clin Invest (1991) 1.36

Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol (2010) 1.35

Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology (2000) 1.33

Infant passenger safety education in perinatal services in California. West J Med (1982) 1.32

Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease. Aliment Pharmacol Ther (2013) 1.32

Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology (2000) 1.32

Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology (1992) 1.28

Functional complementation of a genetic deficiency with human artificial chromosomes. Am J Hum Genet (2001) 1.26

Hepatic changes produced by a single dose of endotoxin in the mouse. Electron microscopy. Am J Pathol (1968) 1.26

Numbers of T cell receptor (TCR) alpha beta+ but not of TcR gamma delta+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. Gut (1993) 1.25

Structure and evolutionary origin of the gene encoding mouse NF-M, the middle-molecular-mass neurofilament protein. Eur J Biochem (1987) 1.24

Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut (2003) 1.23

Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology (2000) 1.22

Interactions between laminin and epithelial cells in intestinal health and disease. Expert Rev Mol Med (2001) 1.21

X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion. J Biol Chem (1998) 1.21

Role of p27(Kip1) in human intestinal cell differentiation. Gastroenterology (2001) 1.19

Successful videocapsule endoscopy in patients with an abdominal cardiac pacemaker. Endoscopy (2007) 1.19

Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol (1988) 1.18

Enhancement of CD3-induced activation of human intestinal intraepithelial lymphocytes by stimulation of the beta 7-containing integrin defined by HML-1 monoclonal antibody. Eur J Immunol (1992) 1.18

Stimulation of mucosal T cells in situ with anti-CD3 antibody: location of the activated T cells and their distribution within the mucosal micro-environment. Clin Exp Immunol (1988) 1.17

Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol (2001) 1.17

Immunocytochemical demonstration of ecto-galactosyltransferase in absorptive intestinal cells. J Cell Biol (1985) 1.17

Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy. Can J Physiol Pharmacol (1996) 1.16

Refractory coeliac sprue is a diffuse gastrointestinal disease. Gut (2003) 1.15

Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem (1994) 1.15

Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig Dis Sci (1997) 1.14

Expression of a normal and variant Alzheimer's beta-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays. Biochem Biophys Res Commun (1990) 1.13

Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells. Am J Physiol (1999) 1.13

Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther (2009) 1.13

Hepatic changes produced by a single dose of endotoxin in the mouse. Light microscopy and histochemistry. Am J Pathol (1967) 1.13

The sequence and gene characterization of a 400-kb candidate region for IDDM4 on chromosome 11q13. Genomics (2001) 1.11

N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase: a metalloendopeptidase of the human intestinal microvillus membrane which degrades biologically active peptides. Arch Biochem Biophys (1988) 1.11

Long-term cimetidine in children with cystic fibrosis: a randomized double-blind study. Pediatr Res (1984) 1.11

IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multicentre study. Eur J Pediatr (1989) 1.11

A monoclonal antibody specific for rat intestinal lymphocytes. J Immunol (1986) 1.10

Small-bowel transplantation in children. Transplant Proc (1990) 1.10

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut (1990) 1.09

Dientamoeba fragilis masquerading as allergic colitis. J Pediatr Gastroenterol Nutr (1998) 1.09

Human cell models to study small intestinal functions: recapitulation of the crypt-villus axis. Microsc Res Tech (2000) 1.08

Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. Biochem Biophys Res Commun (1999) 1.08

Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ (1999) 1.08